Yao-Ling Qiu,Ce Wang,Xiaowen Peng,Lu Ying,Yat Sun Or
申请号：
US12702802
公开号：
US08242156B2
申请日:
2010.02.09
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof:which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
